Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study

BACKGROUND AND AIMS: Real-world data regarding hepatitis B virus-related acute-on-chronic liver failure (HBV-ACLF) patients receiving tenofovir alafenamide (TAF) as an antiviral drug are limited. Hence, we evaluated the efficacy and kidney safety of TAF among this population. METHODS: A total of 272...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Wenting, Gu, Huimin, Cheng, Da, Chen, Keyu, Wu, Cichun, Jiang, Chuan, Liu, Jinqing, Peng, Shifang, Fu, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249370/
https://www.ncbi.nlm.nih.gov/pubmed/37303805
http://dx.doi.org/10.3389/fmicb.2023.1185492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249370/
https://www.ncbi.nlm.nih.gov/pubmed/37303805
http://dx.doi.org/10.3389/fmicb.2023.1185492

Ejemplares similares